TotalMarketCap

Cronos Group

CRONNasdaq CanadaHealth CareMedicinal Chemicals and Botanical Products

Market cap

$1.369 B

$3.72 +5.84%

Close of 6 Nov 2026

As of 6 Nov 2026, Cronos Group (CRON) has a market capitalization of $1.37B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$146.6M

#2379 by revenue

Earnings

-$2.90M

Loss-making

Shares outstanding

366,471,299

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →
  1. #6Trulieve CannabisTRLV$2.11B
  2. #7RLX TechnologyRLX$1.98B
  3. #8Cronos GroupCRON$1.37B
  4. #9Tilray BrandsTLRY$416.0M
  5. #10Orchestra BioMedOBIO$340.2M

What if Cronos Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$76,644.65

Per share 20,631× higher

Bitcoin $1.53T

$4,147.11

Per share 1,116× higher

Apple $5.02T

$13,614.57

Per share 3,665× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Cronos Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.